Kymera Therapeutics
KYMR • NASDAQ
Kymera Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Nello Mainolfi, with a market cap of $7.1B.
Market Cap$7.1B
Employees186.0
CEONello Mainolfi
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
Kymera Therapeutics FAQ
Common questions about Kymera Therapeutics
Kymera Therapeutics is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $9.3M.
Kymera Therapeutics has approximately 186 employees.